ASS1 and lung adenocarcinoma: Based on this premise, the potential role of argininosuccinate synthase 1 (ASS1) [61], a key enzyme in arginine biosynthesis and which we identified as a predictor of sensitivity to HSP90 inhibitors in lung adenocarcinoma, warrants attention.